CytoDyn Inc (CYDY)
0.1470
0.00 (0.00%)
USD |
OTCM |
May 13, 16:00
CytoDyn Net Income (Quarterly): -11.92M for Feb. 29, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -11.92M |
| November 30, 2023 | -9.563M |
| August 31, 2023 | -11.57M |
| May 31, 2023 | -18.64M |
| February 28, 2023 | -13.70M |
| November 30, 2022 | -26.50M |
| August 31, 2022 | -20.99M |
| May 31, 2022 | -84.12M |
| February 28, 2022 | -41.28M |
| November 30, 2021 | -40.08M |
| August 31, 2021 | -45.34M |
| May 31, 2021 | -65.00M |
| February 28, 2021 | -45.21M |
| November 30, 2020 | -35.42M |
| August 31, 2020 | -30.83M |
| May 31, 2020 | -73.14M |
| February 29, 2020 | -35.77M |
| November 30, 2019 | -14.86M |
| August 31, 2019 | -16.16M |
| May 31, 2019 | -14.89M |
| February 28, 2019 | -12.57M |
| November 30, 2018 | -14.31M |
| August 31, 2018 | -14.41M |
| May 31, 2018 | -9.624M |
| February 28, 2018 | -17.95M |
| Date | Value |
|---|---|
| November 30, 2017 | -10.95M |
| August 31, 2017 | -11.63M |
| May 31, 2017 | -6.830M |
| February 28, 2017 | -8.112M |
| November 30, 2016 | -5.467M |
| August 31, 2016 | -5.354M |
| May 31, 2016 | -6.497M |
| February 29, 2016 | -5.047M |
| November 30, 2015 | -5.265M |
| August 31, 2015 | -8.895M |
| May 31, 2015 | -14.00M |
| February 28, 2015 | -2.722M |
| November 30, 2014 | -4.984M |
| August 31, 2014 | -3.380M |
| May 31, 2014 | -2.996M |
| February 28, 2014 | -3.274M |
| November 30, 2013 | -3.588M |
| August 31, 2013 | -2.574M |
| May 31, 2013 | -2.486M |
| February 28, 2013 | -2.359M |
| November 30, 2012 | -1.908M |
| August 31, 2012 | -2.815M |
| May 31, 2012 | -3.392M |
| February 29, 2012 | -1.418M |
| November 30, 2011 | -1.497M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-84.12M
Minimum
May 2022
-9.563M
Maximum
Nov 2023
-32.75M
Average
-28.66M
Median
Net Income (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.108M |
| Palatin Technologies Inc | -7.844M |
| iBio Inc | -8.211M |
| Theriva Biologics Inc | -5.165M |
| Oragenics Inc | -12.75M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.414M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 173.40M |
| Earnings Yield | -34.01% |